On this page
  1. How we cite evidence
  2. Primary MSI-BPD publication
  3. Related clinical literature themes
  4. Authoritative public resources
  5. How this site uses sources
  6. Related guides

Articles

MSI-BPD Scientific References and Sources

Primary MSI-BPD publications, validation context, and authoritative mental health resources used on this site. Screening evidence with study details—not marketing claims.

Published · Edited by the MSI-BPD Screen team

Quick answer

This page lists the MSI-BPD original publication, key validation details, and public clinical resources. We avoid bare accuracy marketing claims without study context.

Key takeaways

  • Primary paper: Zanarini et al., 2003, Journal of Personality Disorders
  • Cutoff context: 7+ in the original validation sample
  • Report sensitivity/specificity only with study, population, and cutoff
  • Authoritative overviews: NIMH and similar public agencies
  • This site is educational screening—not a diagnostic service

How we cite evidence

Every medical-style claim on this site should point to a source. When we mention sensitivity or specificity, we name the study, population, cutoff, and limits. We do not claim “this test is 95% accurate” without that context.

Primary MSI-BPD publication

  1. Zanarini, M. C., Vujanovic, A. A., Parachini, E. A., Boulanger, J. L., Frankenburg, F. R., & Hennen, J. (2003). A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). Journal of Personality Disorders, 17(6), 568–573.
    • PubMed: PMID 14560840
    • Role on this site: instrument description, scoring (0–10), and the commonly cited screening cutoff of 7+ in that validation work.

Validation context (original study)

Details that matter when you read accuracy numbers:

  • Instrument: 10-item yes/no MSI-BPD
  • Cutoff discussed in that work: 7 or higher
  • Comparison: structured clinical interview for BPD (not another online quiz)
  • Reported performance (that study): sensitivity about 0.81, specificity about 0.85 against the interview used in the paper
  • Population: adults with treatment histories in the validation sample (not a random internet sample)

Later studies in other languages, ages, or settings may find different optimal cutoffs. That is expected for screening tools.

These topics appear often when clinicians interpret BPD-related screens. They are starting points for further reading, not a complete bibliography:

  • Differential diagnosis with bipolar disorder, PTSD, ADHD, depression, and anxiety
  • Role of structured interviews versus brief screens
  • Dialectical behavior therapy (DBT) and other evidence-based treatments as clinical pathways—not quiz outcomes

Authoritative public resources

How this site uses sources

  • Homepage scoring copy cites Zanarini et al. for the 7+ screening threshold context.
  • Articles on accuracy and score meaning repeat study limits.
  • Differentials explain overlap, not “if you have X, you have BPD.”

Related guides

Frequently asked questions

Is the MSI-BPD 95% accurate?

We do not use bare marketing figures. Validation metrics depend on the study, population, sample size, and cutoff. See Zanarini et al. (2003) for the original sensitivity and specificity context.

Can I cite this page as a clinical guideline?

No. Use the primary literature and licensed clinicians for clinical decisions. This page is an educational source list.

Back to articles